Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + Placebo

Phase 1Terminated
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rotavirus

Conditions

Rotavirus

Trial Timeline

Jan 1, 2009 → Jan 1, 2010

About Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + Placebo

Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + Placebo is a phase 1 stage product being developed by Merck for Rotavirus. The current trial status is terminated. This product is registered under clinical trial identifier NCT00836498. Target conditions include Rotavirus.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00836498Phase 1Terminated